AMCP Annual 2026 is the premier spring event for managed care pharmacy, bringing 4,000+ professionals to Nashville. As a long-standing AMCP partner, Cencora is pleased to be exhibiting. Visit our booth 1501 to connect with our team and discuss what emerging evidence and market dynamics mean for formulary decision-making and access strategy.
Available in English only
A look inside AMCP Annual
Available in English only
New to AMCP Annual or returning this year? Watch our recap video for a quick look at the experience — from the Expo floor and networking to the pace of the meeting and the conversations shaping managed care pharmacy.
Review the agenda below to plan your time and find opportunities to connect with our team in Nashville.
Review the agenda below to plan your time and find opportunities to connect with our team in Nashville.
Available in English only
Elevate your profile — Visit our sponsored headshot lounge at booth 1501
Thought leadership sessions
Wednesday, April 15 | 9:30 am – 9:45 am
Eye on the Future: Exploring the Latest Payer Trends in Cell and Gene Therapies and Anti-Obesity Medications
Discover how U.S. payers are managing access and formulary decisions for cell and gene therapies and anti‑obesity medications. Drawing on two recent Cencora studies, we will share insights from health plans, PBMs, and IDNs on coverage trends, utilization management, evidence needs, and future expectations, providing biopharma and managed care stakeholders with practical guidance to navigate an evolving payer landscape.
Location: to be confirmed
Speaker: Shaila Yoshida, Assistant Director, Value & Access Strategy
Location: to be confirmed
Speaker: Shaila Yoshida, Assistant Director, Value & Access Strategy
Wednesday, April 15th | 10:15 am - 11:30 am
Unlocking AI's potential in managed care: an actionable roadmap
As AI adoption accelerates, this session explores how AI is reshaping managed care pharmacy today and what to expect by 2030. We’ll review key challenges (fragmented data, formulary inefficiencies, and demand for personalized, value-based care), highlight current AI solutions, and outline what’s next —predictive analytics, automated utilization management, enhanced patient engagement, and more real-time payer decision-making — with a prcticaal roadmap for stakeholders.
Location: Davidson B
Track: Making the way for innovation
Speakers:
Leanna Baker Williams, PharmD, MS, Cencora
Candace Zheng, PharmD, BCPS, RPh, Cencora
Smit Patel, PharmD, Cencora
Sheila Thomas, PharmD, CVS Health
Location: Davidson B
Track: Making the way for innovation
Speakers:
Leanna Baker Williams, PharmD, MS, Cencora
Candace Zheng, PharmD, BCPS, RPh, Cencora
Smit Patel, PharmD, Cencora
Sheila Thomas, PharmD, CVS Health
Wednesday, April 15th | 12:00 pm - 1:00 pm CT
Don’t miss our research during the Expo
Poster 123
Title: Payer perspectives on manufacturer-led direct-to-consumer (DTC) offerings for anti-obesity medications (AOMs)
Authors: Shaila Yoshida, Arvin Sequeira, Michelle Friedman
Poster 206
Title: Practice efficiency and institutional costs associated with epcoritamab + rituximab + lenalidomide in patients with relapsed or refractory follicular lymphoma
Authors: Qianyi Li, Savreet Bains Chawla (Genmab US ), Kellie Meyer, Monika Jun (Genmab US ), Felipe Marques Goncalves (Genmab US ), Matthew Lei (Massachusetts General Hospital)
Title: Payer perspectives on manufacturer-led direct-to-consumer (DTC) offerings for anti-obesity medications (AOMs)
Authors: Shaila Yoshida, Arvin Sequeira, Michelle Friedman
Poster 206
Title: Practice efficiency and institutional costs associated with epcoritamab + rituximab + lenalidomide in patients with relapsed or refractory follicular lymphoma
Authors: Qianyi Li, Savreet Bains Chawla (Genmab US ), Kellie Meyer, Monika Jun (Genmab US ), Felipe Marques Goncalves (Genmab US ), Matthew Lei (Massachusetts General Hospital)
FormularyDecisions® delivers unrivaled opportunities for biopharma companies to reach out to, and connect with, payers
Drive awareness
In the current landscape, it’s harder than ever for biopharma companies to get in-person meetings with payers. FormularyDecisions enables easy outreach to, and engagement with, these critical stakeholders.
Increase engagement
Biopharma companies who fully take advantage of the FormularyDecisions platform and all its features enjoy greater levels of engagement with the payer community, helping build a stronger level of awareness and relationships with payers.
Leverage and understand insights
With direct real-time feedback from payers on a product, biopharma companies can get a better understanding of payer perceptions and refine their information so it resonates better with payers.
Monitor competition
With unparalleled insights into how their product compares with direct competitors, biopharma companies get a full view of the landscape in the therapeutic space, and learn what they can do to stay ahead of the curve.
Partner with experts in strategic guidance, payer strategy, and value storytelling
Need a smarter approach to commercialization and market access?
Our commercialization strategy and market access solutions help ensure speed to market through responsive, solutions-oriented strategies that help drive efficiency in execution and resource allocation to maximize patient access to appropriate therapies.
Meet us at AMCP Annual
Our consultative approach and extensive reach across healthcare give us access to the best insights in the industry — insights we leverage to help commercialization challenges for our partners and patients they serve. Schedule a meeting with our team at AMCP Annual to learn more.